Evidence map›Paper›PMID 28804486›Full record

ArticleFrontiers in immunology2017

First Association of Interleukin 12 Receptor Beta 1 Deficiency with Sjögren's Syndrome.

Georgios Sogkas, Faranaz Atschekzei, Vivien Schacht, Christian von Falck, Alexandra Jablonka, Roland Jacobs, Matthias Stoll, Torsten Witte, Reinhold E Schmidt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Georgios SogkasDivision of Immunology and Rheumatology, Hannover Medical University, Hanover, Germany.
Faranaz AtschekzeiDivision of Immunology and Rheumatology, Hannover Medical University, Hanover, Germany.
Vivien SchachtDivision of Dermatology, Hannover Medical University, Hanover, Germany.
Christian von FalckInstitute for Diagnostic and Interventional Radiology, Hannover Medical University, Hanover, Germany.
Alexandra JablonkaDivision of Immunology and Rheumatology, Hannover Medical University, Hanover, Germany.
Roland JacobsDivision of Immunology and Rheumatology, Hannover Medical University, Hanover, Germany.
Matthias StollDivision of Immunology and Rheumatology, Hannover Medical University, Hanover, Germany.
Torsten WitteDivision of Immunology and Rheumatology, Hannover Medical University, Hanover, Germany.
Reinhold E SchmidtDivision of Immunology and Rheumatology, Hannover Medical University, Hanover, Germany.
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInterleukin 12 receptor beta 1 (IL12Rβ1) deficiency is a primary immunodeficiency resulting mainly in susceptibility to opportunistic infection by non-tuberculous, environmental mycobacteria and severe infection caused by CASE PRESENTATION: We present the case of a 50-year-old male with IL12Rβ1 deficiency due to compound

conclusionApart from persistent antigenic stimulation, which may drive autoimmune inflammation in primary immunodeficiency, evidence on the involvement of interleukin 12 in pathogenesis of SS suggests that the same immunological mechanism may underlie both defense against infection and the maintenance of tolerance. To our knowledge, this is the first report of a case of autoimmunity in the form of SS in a patient with a primary immunodeficiency and one of the rare cases of IL12Rβ1 deficiency with manifested autoimmunity.

Indexed as

autoimmunityinterleukin-12interleukin-12 receptor beta 1 subunitinterleukin-12 receptor beta 1 subunit deficiencyMendelian susceptibility to mycobacterial diseaseprimary immunodeficiencySjögren’s syndrome

Identifiers

PMID28804486
PMCPMC5532512
OpenAlexW2739722932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.